Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Catalyst Pharmaceuticals Inc CPRX

Healthcare Biotechnology
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for... see more

Recent & Breaking News (NDAQ:CPRX)

Catalyst Pharmaceuticals Announces Its Support of Spinal Muscular Atrophy Awareness Month

GlobeNewswire August 1, 2019

Catalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019

GlobeNewswire July 31, 2019

Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration

GlobeNewswire June 12, 2019

Catalyst Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference

GlobeNewswire June 4, 2019

Catalyst Pharmaceuticals Announces Expansion of Firdapse License to Include Japan

GlobeNewswire May 30, 2019

Catalyst Pharmaceuticals Getting Traction as Investors Evaluate the Competition

Press Releases May 14, 2019

Catalyst Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire May 13, 2019

Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Monday, May 13th, 2019

GlobeNewswire May 6, 2019

The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO

Benzinga.com  March 28, 2019

28 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  March 26, 2019

The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs

Benzinga.com  March 26, 2019

52 Biggest Movers From Yesterday

Benzinga.com  March 26, 2019

The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback

Benzinga.com  March 22, 2019

52 Biggest Movers From Yesterday

Benzinga.com  March 21, 2019

41 Stocks Moving In Wednesday's Mid-Day Session

Benzinga.com  March 20, 2019

70 Biggest Movers From Yesterday

Benzinga.com  March 20, 2019

45 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  March 19, 2019

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

GlobeNewswire March 18, 2019

Earnings Scheduled For March 18, 2019

Benzinga.com  March 18, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

Benzinga.com  March 16, 2019